SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review), HIV Medicine, 2014, 15,
  2. 2
    A J Muir, L Gong, S G Johnson, M T M Lee, M S Williams, T E Klein, K E Caudle, D R Nelson, Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-α–Based Regimens, Clinical Pharmacology & Therapeutics, 2014, 95, 2, 141

    CrossRef

  3. 3
    J C Dunkelberg, E M F Berkley, K W Thiel, K K Leslie, Hepatitis B and C in pregnancy: a review and recommendations for care, Journal of Perinatology, 2014, 34, 12, 882

    CrossRef

  4. 4
    Sobia Kanwal, Tariq Mahmood, Hepatitis C virus resistance to interferon therapy: an alarming situation, Central European Journal of Biology, 2014, 9, 12, 1155

    CrossRef

  5. 5
    Giuseppe Indolfi, Giusi Mangone, Pier Luigi Calvo, Elisa Bartolini, Marta Regoli, Daniele Serranti, Carmelina Calitri, Pier-Angelo Tovo, Maurizio de Martino, Chiara Azzari, Massimo Resti, Interleukin 28B rs12979860 Single-Nucleotide Polymorphism Predicts Spontaneous Clearance of Hepatitis C Virus in Children, Journal of Pediatric Gastroenterology and Nutrition, 2014, 58, 5, 666

    CrossRef

  6. 6
    Jessica W. Wen, Barbara A. Haber, Maternal–Fetal Transmission of Hepatitis C Infection, Journal of Pediatric Gastroenterology and Nutrition, 2014, 58, 3, 278

    CrossRef

  7. 7
    Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Guglielmo Borgia, Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus, Expert Review of Anti-infective Therapy, 2014, 12, 7, 775

    CrossRef

  8. 8
    Heidar Sharafi, Seyed Moayed Alavian, Bita Behnava, Ali Pouryasin, Maryam Keshvari, The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study, Hepatitis Monthly, 2014, 14, 10

    CrossRef

  9. 9
    Brad S. Thomas, Michael A. Joyce, Aviad Levin, D. Lorne J. Tyrrell, Validation of TaqMan® SNP genotyping specificity for rs12979860 of IL-28B: Modeling primer specificity in vitro, Journal of Virological Methods, 2014, 203, 39

    CrossRef

  10. 10
    Rosa Quiles-Pérez, Esther José Pavón-Castillero, Paloma Muñoz-de-Rueda, Isabel Carmona, Javier Salmerón, Valor de la genética en la era de la terapia triple frente al virus de la hepatitis C, Gastroenterología y Hepatología, 2014, 37, 7, 427

    CrossRef

  11. 11
    Pathologies maternelles et grossesse, 2014,

    CrossRef

  12. 12
    Haruki Komatsu, Ayano Inui, Tomoyuki Tsunoda, Tsuyoshi Sogo, Tomoo Fujisawa, Association between an IL-28B genetic polymorphism and the efficacy of the response-guided pegylated interferon therapy in children with chronic hepatic C infection, Hepatology Research, 2013, 43, 4
  13. 13
    Cameron J Schweitzer, T Jake Liang, Impact of host and virus genome variability on HCV replication and response to interferon, Current Opinion in Virology, 2013, 3, 5, 501

    CrossRef

  14. 14
    K. Domagalski, M. Pawłowska, A. Tretyn, W. Halota, M. Pilarczyk, E. Smukalska, K. Linkowska, T. Grzybowski, Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4, European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32, 6, 745

    CrossRef

  15. 15
    Giuseppe Indolfi, Chiara Azzari, Massimo Resti, Perinatal Transmission of Hepatitis C Virus, The Journal of Pediatrics, 2013, 163, 6, 1549

    CrossRef

  16. You have free access to this content16
    11.0 References, HIV Medicine, 2012, 13,
  17. You have free access to this content17
    6.0 HIV and hepatitis virus coinfections, HIV Medicine, 2012, 13,
  18. 18
    Mohammad Hashemi, Abdolkarim Moazeni-roodi, Ali Bahari, Mohsen Taheri, A Tetra-Primer Amplification Refractory Mutation System–Polymerase Chain Reaction for the Detection of rs8099917 IL28B Genotype, Nucleosides, Nucleotides and Nucleic Acids, 2012, 31, 1, 55

    CrossRef

  19. 19
    Hans L. Tillmann, Acute HCV: Will IL28B Testing Change the Paradigm?, Current Hepatitis Reports, 2012, 11, 1, 10

    CrossRef

  20. 20
    Mostafa K. El-Awady, Lotiaf Mostafa, Ashraf A. Tabll, Tawfeek H. Abdelhafez, Noha G.Bader El Din, Naglaa Zayed, Reem El Shenawy, Yasmin El Abd, Reham M. Hasan, Hosam Zaghlol, Hesham El Khayat, Ashraf O. Abdel Aziz, Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease, Hepatitis Monthly, 2012, 12, 4, 271

    CrossRef

  21. 21
    Jie Chen, Yi Li, Lanlan Wang, Yang Fu, Yun Liao, Junlong Zhang, Association of three SNPs in interleukin-28B with graft hepatic dysfunction after liver transplantation in Chinese Han population, Gene, 2012, 508, 1, 121

    CrossRef

  22. You have free access to this content22
    GP Taylor, P Clayden, J Dhar, K Gandhi, Y Gilleece, K Harding, P Hay, J Kennedy, N Low-Beer, H Lyall, A Palfreeman, P Tookey, S Welch, E Wilkins, A de Ruiter, British HIV Association guidelines for the management of HIV infection in pregnant women 2012, HIV Medicine, 2012, 13,
  23. 23
    Liz Alvarez-Lajonchere, Santiago Dueñas-Carrera, Complete Definition of Immunological Correlates of Protection and Clearance of Hepatitis C Virus Infection: A Relevant Pending Task for Vaccine Development, International Reviews of Immunology, 2012, 31, 3, 223

    CrossRef

  24. 24
    C. Nelson Hayes, Michio Imamura, Hiroshi Aikata, Kazuaki Chayama, Genetics of IL28B and HCV—response to infection and treatment, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 7, 406

    CrossRef

  25. 25
    Ozlem Durmaz, Hepatitis C infection in childhood, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 3, 294

    CrossRef

  26. You have free access to this content26
    Douglas Mogul, Kathleen B. Schwarz, Hepatitis C viral infection in children, Clinical Liver Disease, 2012, 1, 3
  27. 27
    Takeshi Endo, Koichi Ito, Tokio Sugiura, Kenji Goto, Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child, Case Reports in Medicine, 2012, 2012, 1

    CrossRef

  28. 28
    Qing-He Nie, Lu-Hua Gao, Yong-Qian Cheng, Xiao-Feng Huang, Ya-Fei Zhang, Xin-Dong Luo, Jun-Qing Wang, Yuan-Yuan Wang, Hepatitis C virus infection of human cytotrophoblasts cultured in vitro, Journal of Medical Virology, 2012, 84, 10
  29. 29
    Christoph T. Berger, Arthur Y. Kim, IL28B Polymorphisms as a Pretreatment Predictor of Response to HCV Treatment, Infectious Disease Clinics of North America, 2012, 26, 4, 863

    CrossRef

  30. 30
    Anthony F. Porto, Lauren Tormey, Joseph K. Lim, Management of chronic hepatitis C infection in children, Current Opinion in Pediatrics, 2012, 24, 1, 113

    CrossRef

  31. 31
    Y. Chen, H.-X. Xu, L.-J. Wang, X.-X. Liu, R. I. Mahato, Y.-R. Zhao, Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin, Alimentary Pharmacology & Therapeutics, 2012, 36, 2
  32. 32
    Cara L. Mack, Regino P. Gonzalez-Peralta, Nitika Gupta, Daniel Leung, Michael R. Narkewicz, Eve A. Roberts, Philip Rosenthal, Kathleen B. Schwarz, NASPGHAN Practice Guidelines, Journal of Pediatric Gastroenterology and Nutrition, 2012, 54, 6, 838

    CrossRef

  33. 33
    Oliver Bauhofer, Alessia Ruggieri, Bianca Schmid, Peter Schirmacher, Ralf Bartenschlager, Persistence of HCV in Quiescent Hepatic Cells Under Conditions of an Interferon-Induced Antiviral Response, Gastroenterology, 2012, 143, 2, 429

    CrossRef

  34. 34
    V. Soriano, E. Poveda, E. Vispo, P. Labarga, N. Rallon, P. Barreiro, Pharmacogenetics of hepatitis C, Journal of Antimicrobial Chemotherapy, 2012, 67, 3, 523

    CrossRef

  35. 35
    Dae Won Jun, Won Young Tak, Si Hyun Bae, Youn Jae Lee, Recent trends in the treatment of chronic hepatitis C, The Korean Journal of Hepatology, 2012, 18, 1, 22

    CrossRef

  36. 36
    Dae Won Jun, Treatment of chronic hepatitis C, Journal of the Korean Medical Association, 2012, 55, 11, 1113

    CrossRef

  37. 37
    Martin Lagging, Ann-Sofi Duberg, Rune Wejstål, Ola Weiland, Magnus Lindh, Soo Aleman, Filip Josephson, Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations, Scandinavian Journal of Infectious Diseases, 2012, 44, 7, 502

    CrossRef

  38. 38
    Małgorzata Pawłowska, Waldemar Halota, Ewa Smukalska, Vertical genotype 1 HCV infection treated successfully in the second year of life: A case report, Medical Science Monitor, 2012, 18, 12, CS113

    CrossRef

  39. 39
    Juan Macías, Eugenia Vispo, Juan A. Pineda, Vicente Soriano, Host genetics, Current Opinion in HIV and AIDS, 2011, 6, 6, 491

    CrossRef

  40. 40
    Susan Farmand, Stefan Wirth, Philipp Henneke, Reply to the correspondence letter by Dr. Giuseppe Indolfi “Spontaneous clearance of hepatitis C virus in vertically infected children. Any clue for treatment?”, European Journal of Pediatrics, 2011, 170, 12, 1623

    CrossRef

  41. 41
    Giuseppe Indolfi, Elisa Bartolini, Massimo Resti, Spontaneous clearance of hepatitis C virus in vertically infected children: any clue for treatment?, European Journal of Pediatrics, 2011, 170, 12, 1621

    CrossRef